BIC-EMTAF Tablet is a highly effective once-daily antiretroviral medicine used for the treatment of HIV-1 infection in adults and adolescents. It is a fixed-dose combination of three powerful antiviral agents — Bictegravir, Emtricitabine, and Tenofovir Alafenamide (TAF) — designed to suppress the virus, improve immune function, and help patients achieve an undetectable viral load.
BIC-EMTAF simplifies HIV treatment by combining three medicines in a single tablet, improving adherence and long-term treatment outcomes.
Composition of BIC-EMTAF Tablet
Each tablet contains:
- Bictegravir – 50 mg
- Emtricitabine – 200 mg
- Tenofovir Alafenamide (TAF) – 25 mg
Drug Class: Integrase Strand Transfer Inhibitor (INSTI) + Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Uses of BIC-EMTAF Tablet
BIC-EMTAF Tablet is prescribed for:
- Treatment of HIV-1 infection in adults and adolescents (weighing ≥25 kg)
- Reducing viral load to undetectable levels when taken regularly
- Improving CD4 cell count and boosting the immune system
- Preventing progression of HIV to AIDS and reducing the risk of opportunistic infections
How BIC-EMTAF Tablet Works
BIC-EMTAF combines three different mechanisms of action to deliver potent viral suppression:
- Bictegravir inhibits the integrase enzyme, stopping HIV from inserting its DNA into human cells.
- Emtricitabine and Tenofovir Alafenamide are NRTIs that block reverse transcriptase, preventing viral replication.
This triple-drug combination attacks the virus at multiple stages, resulting in strong and durable viral suppression.
Dosage and Administration
Recommended dose: One tablet once daily, with or without food
Take the medicine at the same time each day to maintain consistent drug levels
Do not skip doses or stop treatment without your doctor’s advice
Follow your healthcare provider’s instructions for the best results
Side Effects of BIC-EMTAF Tablet
Common side effects may include:
- Headache
- Nausea
- Diarrhea
- Fatigue
- Insomnia (difficulty sleeping)
Serious but uncommon side effects:
- Liver problems
- Kidney issues
- Changes in bone mineral density
- Allergic reactions
👉 Contact your doctor immediately if you experience severe or persistent side effects.
Precautions and Warnings
- Prescription-only medicine – use under medical supervision only
- Inform your doctor if you have liver disease, kidney disease, or bone problems
- Avoid alcohol, as it may increase the risk of liver complications
- Pregnant or breastfeeding women should consult a doctor before use
- Continue safe practices (like using protection), as the medicine does not prevent HIV transmission
- Regular blood tests may be required to monitor health during treatment
Storage Instructions
- Store at room temperature (below 30°C)
- Keep away from moisture, direct sunlight, and heat
- Keep out of reach of children and pets
Why Buy BIC-EMTAF Tablet from Us?
- 100% authentic and genuine medicines
- Affordable pricing with regular discounts
- Discreet packaging to maintain privacy
- Fast and reliable doorstep delivery across India
- Trusted and licensed online pharmacy
FAQs about BIC-EMTAF Tablet
- Q1. Is BIC-EMTAF a cure for HIV?
- No. BIC-EMTAF is not a cure, but it helps control the virus, reduce viral load to undetectable levels, and support long-term health.
- Q2. Can BIC-EMTAF be taken alone?
- Yes. BIC-EMTAF is a complete single-tablet regimen, meaning it contains all the medicines needed for most people with HIV-1 infection.
- Q3. What if I miss a dose?
- Take the missed dose as soon as you remember. If it’s close to the next dose, skip the missed one. Do not double the dose.
- Q4. How long should I take BIC-EMTAF?
- HIV treatment is usually lifelong. Continue taking it as prescribed unless advised otherwise by your doctor.
Why BIC-tegravir may be preferable to dolutegravir (DTG) in first-line ART
- Slightly better tolerability & lower adverse event burden — In long-term trials, BIC/FTC/TAF regimens had fewer drug-related adverse events compared with regimens containing DTG (especially GI symptoms, neuropsychiatric complaints) over 96 weeks.
- Comparable or modest incremental virologic advantage — BIC has shown noninferiority (and in some settings a slight edge at early time points) compared to DTG-based regimens in randomized trials and observational switch studies.
- Pharmacokinetic & binding properties — BIC is metabolized via both CYP3A4 and UGT1A1, offering a favorable drug interaction profile in many settings. Also, the albumin binding characteristics of BIC may help maintain an adequate unbound (active) fraction without overly tight sequestration.
- Metabolic / weight / cardiometabolic profile
- Some observational data suggest that switching to a BIC regimen is associated with lower annualized weight gain than prior regimens. In one cohort, post-switch annual weight gain was –0.88 kg/year (i.e., actually less gain than before switch) for BIC/FTC/TAF, versus –0.39 kg/year for DTG-based switch regimens (though this difference did not reach strong statistical significance).
- In long-term trial comparisons (up to 144 weeks), no major differences in weight, BMI, or incidence of metabolic disorders (diabetes, hypertension) were consistently observed between BIC and DTG regimens.
- While the data do not strongly prove a “metabolic protection” advantage for BIC over DTG, the tolerability, slightly lower AE rate, and trends of more favorable weight trajectories make BIC an appealing choice in patients at higher risk for metabolic complications (e.g., those with baseline overweight, insulin resistance, cardiovascular risk).
- “Forgiveness” and durability — Some real-world analyses suggest that switching to a BIC-based regimen may maintain viral suppression slightly more “forgivingly” in settings of imperfect adherence compared to staying on DTG regimens.
BIC-EMTAF Tablet (Bictegravir + Emtricitabine + Tenofovir Alafenamide) is a trusted, modern antiretroviral combination for managing HIV infection effectively. With its single-tablet regimen, it simplifies treatment, enhances adherence, and delivers strong viral suppression.
Order BIC-EMTAF Tablet online today from a licensed pharmacy for genuine medicines, fast delivery, and complete privacy.